INS and diabetes mellitus: Compared with ACEI/ARB, sacubitril/valsartan treatment did not significantly reduce the subsequent use of oral antihyperglycaemic or insulin treatment among patients with new-onset DM (RR = 1.17, 95% CI: 0.82–1.66, p = 0.39) (Additional file 4: Fig. S8).